Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anett, Balikó"'
Autor:
Anett Balikó, Zsolt Szakács, Béla Kajtár, Zsombor Ritter, Attila Gyenesei, Nelli Farkas, László Kereskai, István Vályi-Nagy, Hussain Alizadeh, László Pajor
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe clinical and genetic heterogeneity of diffuse large B-cell lymphoma (DLBCL) presents distinct challenges in predicting response to therapy and overall prognosis. The main objective of this study was to assess the application of the immu
Externí odkaz:
https://doaj.org/article/ec447b4b9ede41b9a351b70e01ea0993
Autor:
Zsolt Szakács, MD, PhD, Amar Lal, MD, Jorgen Kristensen, MD, PhD, Nelli Farkas, PhD, Zsombor Ritter, MD, Szabolcs Kiss, MD, Hussain Alizadeh, MD, PhD, Anett Balikó, MD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 5, Pp 100882- (2022)
Purpose: B-cell non-Hodgkin lymphomas (NHLs) are significant contributors to cancer-related mortality. In this single-arm, retrospective cohort study, we aimed to examine the outcomes of a radioimmunotherapeutic modality, 90Y-labeled ibritumomab tiux
Externí odkaz:
https://doaj.org/article/901b513152ba4722983b6960ba6b1c10
Autor:
Zsombor Ritter, László Papp, Katalin Zámbó, Zoltán Tóth, Dániel Dezső, Dániel Sándor Veres, Domokos Máthé, Ferenc Budán, Éva Karádi, Anett Balikó, László Pajor, Árpád Szomor, Erzsébet Schmidt, Hussain Alizadeh
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeFor the identification of high-risk patients in diffuse large B-cell lymphoma (DLBCL), we investigated the prognostic significance of in vivo radiomics derived from baseline [18F]FDG PET/CT and clinical parameters.MethodsPre-treatment [18F]FDG
Externí odkaz:
https://doaj.org/article/23b4f1b86d1f451eafd198a7cf1d591b
Autor:
Zsombor, Ritter, László, Papp, Katalin, Zámbó, Zoltán, Tóth, Dániel, Dezső, Dániel Sándor, Veres, Domokos, Máthé, Ferenc, Budán, Éva, Karádi, Anett, Balikó, László, Pajor, Árpád, Szomor, Erzsébet, Schmidt, Hussain, Alizadeh
Publikováno v:
Frontiers in oncology. 12
For the identification of high-risk patients in diffuse large B-cell lymphoma (DLBCL), we investigated the prognostic significance ofPre-treatment [The automated machine learning analysis of the Center 1 dataset revealed that the most important featu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::daa0e6fb844e4032d560e1d1dac034ab
https://pubmed.ncbi.nlm.nih.gov/35756658
https://pubmed.ncbi.nlm.nih.gov/35756658